The Pharma Data

FEBRUARY 21, 2022

Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.

Radiology 52

Radiology Cardiology Development Production 52

pharmaphorum

MARCH 31, 2021

Billed as a future blockbuster, Lutathera added $445 million in sales last year, although its growth was pegged back by the pandemic as it needs to be administered in a hospital location. billion or more in peak sales. “We believe this technology has the potential to transform many patients’ lives,” she added.

Licensing 98

Licensing Licensing Gene Therapy Sales 98

The Pharma Data

AUGUST 5, 2021

Group sales increase by 12.9 Sales at all divisions increased by a double-digit percentage after adjusting for currency and portfolio effects, and we expect this positive sales momentum to continue in all our businesses. Group sales in the second quarter increased by 12.9 Group sales in the second quarter increased by 12.9

Sales 52

Sales Production Gene Therapy Allergies 52

The Pharma Data

OCTOBER 1, 2021

Dr. Olaf Weber, Head of Radiology Research and Development at Bayer. About Radiology at Bayer Everyone deserves clear answers about their health, starting with an early and accurate diagnosis. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 mmol/kg weight. “At billion euros. billion euros.

Radiology 52

Radiology Life Science Development Production 52

pharmaphorum

SEPTEMBER 30, 2022

He pointed out that services to administer the injections frequently, and the required radiology and clinical monitoring for patients, “will all need to be factored in on top of the simple cost of the drug.” “It is very likely more people will come to see their doctor now – and we, as doctors, need to be ready. .”

Clinical Trials 52

Clinical Trials Clinical Trials Sales Drugs 52

XTalks

JUNE 12, 2023

Abbott Laboratories reported that the sales from its Diagnostics and Medical Device divisions in 2022 surpassed the company’s initial forecast. The remarkable performance in 2022 was driven largely by the sales of COVID-19 testing kits, including the BinaxNOW COVID-19 Ag test and its at-home self-test version. percent from $27.06

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

pharmaphorum

MARCH 16, 2022

Although not strictly part of the novel-format discussion, the European Society of Radiology (ESR) has announced that its annual ECR 2022 congress will follow a ‘two-in-one‘ format: an online introductory event featuring the highlights of the scientific and educational programme of the main onsite-and-online event scheduled at a later date.

Doctor 98

Doctor Doctors Marketing Radiology 98

pharmaphorum

APRIL 7, 2021

The drug made $445 million in sales last year. Novartis already sells one radioligand therapy – Lutathera (177Lu- oxodotreotide) for neuroendocrine tumours – which it acquired for $3.9 billion along with its developer Advanced Accelerator Applications in 2017.

DNA 52

DNA Licensing Licensing Gene Therapy 52

XTalks

AUGUST 30, 2022

Global sales of over-the-counter and prescription products related to central nervous system (CNS) disease added up to $86 billion in 2019. The Neurology and Radiology departments are vital for consultation and imaging, which is needed to establish baselines for a study.

Trials 83

Trials Drug Delivery Drugs Gene 83

The Pharma Data

DECEMBER 23, 2020

Department of Defense (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in coordination with the Office of the Assistant Secretary of Defense for Health Affairs (OASD(HA)) and the Defense Health Agency (DHA). It will be funded by the U.S.

DNA 40

DNA Vaccine Vaccination Immune Response 40

Delveinsight

DECEMBER 29, 2020

billion – a deal that is split into upfront payments, and sales and regulatory milestone payments. The company boasts of its wide spectrum of portfolio ranging from solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology, and respiratory care.

Trials 52

Trials Drugs Hormones Radiology 52

The Pharma Data

JUNE 25, 2021

Under the terms of the licensing agreement with Vanderbilt, AstraZeneca will pay single-digit royalties on future net sales. W911QY-21-9-0001. Preliminary ‘in vitro’ findings from investigators at Oxford University and Columbia University also demonstrate that AZD7442 neutralises recent emergent SARS-CoV-2 viral variants.

Trials 52

Trials Antibody In-Vitro Medicine 52

XTalks

FEBRUARY 14, 2025

Strategic moves including an 80% acquisition of PRISM Vision Holdings and the sale of its Canadian retail businesses have boosted its outlook. More recently, the company introduced a cutting-edge mobile stroke unit and sustainable radiology technologies to enhance patient care and operational efficiency.

Marketing 59

Marketing Pharmacy Radiology Cardiology 59

The Pharma Data

AUGUST 22, 2021

Under the terms of the licensing agreement with Vanderbilt, AstraZeneca will pay single-digit royalties on future net sales. W911QY-21-9-0001. About AstraZeneca.

Trials 52

Trials Antibody Vaccine Vaccination 52

The Pharma Data

MAY 3, 2021

Radiology Partners, Aidoc talk AI adoption, handling bias, FDA actions ( MedtechDive ). Siemens raises outlook as COVID-19 antigen tests blast past original sales target ( MedtechDive ). Siemens raises outlook as COVID-19 antigen tests blast past original sales target ( MedtechDive ).

Gene Therapy 52

Gene Therapy Vaccine Vaccination Bioequivalency 52

XTalks

SEPTEMBER 14, 2020

If retail sales were the sole indicator that the US economy is recovering, the country would have something to cheer about. According to the Commerce Department, retail sales rose 7.5 Retail sales in the UK have bounced back to relatively high levels, even though initially, sales were extremely anemic, with only a 0.9

Vaccine 92

Vaccine Vaccination Antibody Life Science 92